Document is current
Any future updates will be listed below
-
Authors
Zheng, Danping
Mohapatra, Gayatree
Kern, Lara http://orcid.org/0000-0001-8399-6293
He, Yiming
Shmueli, Merav D. http://orcid.org/0000-0002-9196-7633
Valdés-Mas, Rafael
Kolodziejczyk, Aleksandra A. http://orcid.org/0000-0002-2903-8884
Próchnicki, Tomasz
Vasconcelos, Matilde B. http://orcid.org/0000-0003-1487-6495
Schorr, Lena http://orcid.org/0000-0002-3781-5663
Hertel, Franziska http://orcid.org/0000-0003-1347-5753
Lee, Ye Seul
Rufino, Miguel Camacho
Ceddaha, Emmanuelle
Shimshy, Sandy
Hodgetts, Ryan James
Dori-Bachash, Mally
Kleimeyer, Christian
Goldenberg, Kim
Heinemann, Melina
Stettner, Noa
Harmelin, Alon
Shapiro, Hagit
Puschhof, Jens
Chen, Minhu
Flavell, Richard A. http://orcid.org/0000-0003-4461-0778
Latz, Eicke http://orcid.org/0000-0003-1488-5666
Merbl, Yifat http://orcid.org/0000-0002-3465-2221
Abdeen, Suhaib K.
Elinav, Eran http://orcid.org/0000-0002-5775-2110
- License Information
-
More Information
Article History
Received: 25 January 2022
Accepted: 6 February 2023
First Online: 20 March 2023
Competing interests
: E.L. is cofounder and consultant of IFM Therapeutics and Odyssey Therapeutics as well as cofounder and board member of Dioscure Therapeutics and Stealth Biotech. E.E. is a scientific founder of DayTwo and BiomX, and a paid consultant to Hello Inside, Igen and Aposense, in topics unrelated to this manuscript. The other authors declare no competing interests.
